Intelligence · Clinical Pipeline
SUPERNUS PHARMACEUTICALS Pipeline
All ClinicalTrials.gov programs at SUPERNUS PHARMACEUTICALS — phase, modality, and trial IDs.
- Programs
- 8
Quick answer
SUPERNUS PHARMACEUTICALS has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
BIS-001 ER
SUPERNUS PHARMACEUTICALS, INC.
Epilepsy, Complex Partial
1 trial -
SAGE-718
SUPERNUS PHARMACEUTICALS, INC.
Healthy Volunteer
3 trials -
SAGE-904
SUPERNUS PHARMACEUTICALS, INC.
Healthy Volunteer
1 trial -
SPN-804O
SUPERNUS PHARMACEUTICALS, INC.
Epilepsies, Partial
1 trial -
SPN-810M
SUPERNUS PHARMACEUTICALS, INC.
Impulsive Aggression Comorbid With ADHD
1 trial -
SPN-817, Treatment B
SUPERNUS PHARMACEUTICALS, INC.
Healthy Volunteer
1 trial -
Topiramate IR
SUPERNUS PHARMACEUTICALS, INC.
Epilepsy
1 trial -
[14C]-NV-5138
SUPERNUS PHARMACEUTICALS, INC.
Healthy Volunteers
2 trials
Frequently asked questions
How many pipeline programs does SUPERNUS PHARMACEUTICALS have?
8 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs